CE Opportunities By Credit Type

CE Opportunities

By Credit Type

AAPA

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing...

Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis

RELEASE DATE: October 1, 2020 EXPIRATION DATE: September 30, 2021 The...

Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Release Date: September 25, 2020 Valid for Credit Through: September...

IJMSC: Outdoor Adventure Programs for Persons with Multiple Sclerosis: A Review and Agenda for Future Research

Release Date: August 1, 2021 Valid for Credit Through: August...

Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now

Release Date: June 29, 2021 Expiration Date: June 29, 2022...

IJMSC: CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis

This consensus document was developed by an international panel of...

ECHO MS

Description ECHO MS implements the evidence-based hub and spoke ECHO...

IJMSC: Trekking Poles to Aid Multiple Sclerosis Walking Impairment: An Exploratory Comparison of the Effects of Assistive Devices on Psychosocial Impact and Walking

Release Date: June1, 2021 Valid for Credit Through: June 1,...

IJMSC: Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis

Release Date: April1, 2021 Valid for Credit Through: April 1,...

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing...

AIMS Peer-to-Peer Podcasts

New Podcasts Available for Clinicians to Earn CE Credit! Earn...

Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management

Released: January 11, 2021 Expires: January 11, 2022 Program Description...

Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration...

IJMSC: Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis

Release Date: February 1, 2021 Valid for Credit Through: February...

Examining the Evidence for Early Initiation of Disease-Modifying Therapy

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

Exploring the Use of Diagnostic Tools to Improve Early Detection of MS

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

Clinical Insights on When and How to Switch DMT in Patients With a Suboptimal Treatment Response

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

What Is Disease Modifying Therapy? Evidence-Based Disease Modification in Multiple Sclerosis

RELEASE DATE: December 30, 2020 VALID FOR CREDIT THROUGH: December...

IJMSC: I Will Respect the Autonomy of My Patient: A Scoping Review of Shared Decision Making in Multiple Sclerosis

Release Date: December 1, 2020 Valid for Credit Through: December...

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October...

Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care

Released: November 13, 2020 Expires: November 13, 2021 Provided by...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Next-Generation S1P Modulators in MS Management

Released: October 30, 2020 Expires: October 30, 2021 Jointly Accredited...

Patient Considerations When Selecting Disease-Modifying Therapy in Multiple Sclerosis

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October...

Differing Perspectives on Multiple Sclerosis Nursing Care

Release Date: October 20, 2020 Valid for Credit Through: October...

Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) — An ACTRIMS-ECTRIMS Virtual Satellite

Reshaping the Paradigm: Implications of Recent Clinical Advances in the...

IJMSC: Comparing Health Promotion and Quality of Life in People with Progressive Versus Nonprogressive Multiple Sclerosis

Release Date: October 1, 2020 Valid for Credit Through: October...

The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis

RELEASE DATE: October 1, 2020 EXPIRATION DATE: September 30, 2021 The...

Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Release Date: September 25, 2020 Valid for Credit Through: September...

Journal Club: The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis

Release Date: August 24, 2020 Valid for Credit Through: August...

Precision Medicine with Polypharmacy in Multiple Sclerosis: What does it mean in practice?

RELEASE DATE: July 15, 2020 EXPIRATION DATE: September 14, 2021 Precision Medicine...

Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now

Release Date: June 29, 2021 Expiration Date: June 29, 2022...

ECHO MS

Description ECHO MS implements the evidence-based hub and spoke ECHO...

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing...

Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management

Released: January 11, 2021 Expires: January 11, 2022 Program Description...

Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration...

Examining the Evidence for Early Initiation of Disease-Modifying Therapy

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

Exploring the Use of Diagnostic Tools to Improve Early Detection of MS

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

Clinical Insights on When and How to Switch DMT in Patients With a Suboptimal Treatment Response

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

What Is Disease Modifying Therapy? Evidence-Based Disease Modification in Multiple Sclerosis

RELEASE DATE: December 30, 2020 VALID FOR CREDIT THROUGH: December...

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October...

Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care

Released: November 13, 2020 Expires: November 13, 2021 Provided by...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Next-Generation S1P Modulators in MS Management

Released: October 30, 2020 Expires: October 30, 2021 Jointly Accredited...

Patient Considerations When Selecting Disease-Modifying Therapy in Multiple Sclerosis

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October...

Differing Perspectives on Multiple Sclerosis Nursing Care

Release Date: October 20, 2020 Valid for Credit Through: October...

Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) — An ACTRIMS-ECTRIMS Virtual Satellite

Reshaping the Paradigm: Implications of Recent Clinical Advances in the...

The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis

RELEASE DATE: October 1, 2020 EXPIRATION DATE: September 30, 2021 The...

Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Release Date: September 25, 2020 Valid for Credit Through: September...

Journal Club: The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis

Release Date: August 24, 2020 Valid for Credit Through: August...

Precision Medicine with Polypharmacy in Multiple Sclerosis: What does it mean in practice?

RELEASE DATE: July 15, 2020 EXPIRATION DATE: September 14, 2021 Precision Medicine...

IJMSC: Outdoor Adventure Programs for Persons with Multiple Sclerosis: A Review and Agenda for Future Research

Release Date: August 1, 2021 Valid for Credit Through: August...

Clinical Consultations™: SARS-CoV-2 Vaccination in Patients with MS – What Clinicians Need to Know Now

Release Date: June 29, 2021 Expiration Date: June 29, 2022...

IJMSC: CMSC Consensus Statement on Neurofilament Biomarkers in Multiple Sclerosis

This consensus document was developed by an international panel of...

ECHO MS

Description ECHO MS implements the evidence-based hub and spoke ECHO...

IJMSC: Trekking Poles to Aid Multiple Sclerosis Walking Impairment: An Exploratory Comparison of the Effects of Assistive Devices on Psychosocial Impact and Walking

Release Date: June1, 2021 Valid for Credit Through: June 1,...

IJMSC: Variables Associated with Self-reported Language Impairment in Multiple Sclerosis: A Regression Analysis

Release Date: April1, 2021 Valid for Credit Through: April 1,...

Therapeutic Advances in the Management of Relapsing Forms of Multiple Sclerosis

Release Date: 3/12/2021 Expiration Date: 3/11/2022 Provider Statement This continuing...

AIMS Peer-to-Peer Podcasts

New Podcasts Available for Clinicians to Earn CE Credit! Earn...

Immune Dysfunction in Multiple Sclerosis: Modern Considerations in Treatment and Management

Released: January 11, 2021 Expires: January 11, 2022 Program Description...

Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration...

IJMSC: Identifying Barriers to and Facilitators of Health Service Access Encountered by Individuals with Multiple Sclerosis

Release Date: February 1, 2021 Valid for Credit Through: February...

Examining the Evidence for Early Initiation of Disease-Modifying Therapy

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

Exploring the Use of Diagnostic Tools to Improve Early Detection of MS

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

Clinical Insights on When and How to Switch DMT in Patients With a Suboptimal Treatment Response

RELEASE DATE: December 21, 2020 VALID FOR CREDIT THROUGH: December...

Advancing the Role of the Nurse in the Management of MS in Rural Areas: An Online Curriculum

This online curriculum provides up-to-date information related to the comprehensive...

What Is Disease Modifying Therapy? Evidence-Based Disease Modification in Multiple Sclerosis

RELEASE DATE: December 30, 2020 VALID FOR CREDIT THROUGH: December...

IJMSC: I Will Respect the Autonomy of My Patient: A Scoping Review of Shared Decision Making in Multiple Sclerosis

Release Date: December 1, 2020 Valid for Credit Through: December...

The New Era of Neuromyelitis Optica Spectrum Disorder: Advances in Diagnosis and Treatment

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October...

Cases in Multiple Sclerosis Treatment: Evidence-Based Approaches to Optimal Care

Released: November 13, 2020 Expires: November 13, 2021 Provided by...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Next-Generation S1P Modulators in MS Management

Released: October 30, 2020 Expires: October 30, 2021 Jointly Accredited...

Patient Considerations When Selecting Disease-Modifying Therapy in Multiple Sclerosis

RELEASE DATE: October 21, 2020 VALID FOR CREDIT THROUGH: October...

Differing Perspectives on Multiple Sclerosis Nursing Care

Release Date: October 20, 2020 Valid for Credit Through: October...

Reshaping the Paradigm: Implications of Recent Clinical Advances in the Diagnosis and Treatment of Neuromyelitis Optica Spectrum Disorder (NMOSD) — An ACTRIMS-ECTRIMS Virtual Satellite

Reshaping the Paradigm: Implications of Recent Clinical Advances in the...

IJMSC: Comparing Health Promotion and Quality of Life in People with Progressive Versus Nonprogressive Multiple Sclerosis

Release Date: October 1, 2020 Valid for Credit Through: October...

The Iceberg Effect: Subclinical Disease Activity in Multiple Sclerosis

RELEASE DATE: October 1, 2020 EXPIRATION DATE: September 30, 2021 The...

Journal Club: Monoclonal Antibody Treatment during Pregnancy and/or Lactation in Women with MS or Neuromyelitis Optica Spectrum Disorder

Release Date: September 25, 2020 Valid for Credit Through: September...

Journal Club: The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis

Release Date: August 24, 2020 Valid for Credit Through: August...

Precision Medicine with Polypharmacy in Multiple Sclerosis: What does it mean in practice?

RELEASE DATE: July 15, 2020 EXPIRATION DATE: September 14, 2021 Precision Medicine...

AOTA

No posts found!

APA

Initiating or Switching Therapy in Multiple Sclerosis: New Evidence and Expert Insights

*US and Canadian HCPs* Release Date: November 30, 2020 Expiration...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Journal Club: The Dilemma of When to Stop Disease-Modifying Therapy in Multiple Sclerosis

Release Date: August 24, 2020 Valid for Credit Through: August...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 1: Fundamentals of Cannabis

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 2: Cannabis as an Herbal Medicine – Efficacy/Side Effect Considerations and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...

Cannabis and MS: Helping Patients Understand Risks and Benefits Session 3: Pharmacology and Interactions, Trial Data, DMTs, and Case Studies

CANNABIS AND MS: HELPING PATIENTS UNDERSTAND RISKS AND BENEFITS SESSION...